Screening and Early Detection of Lung Cancer

DuyKhanh P. Ceppa, MD, Vignesh Raman, MD, MHS, Tina D. Tailor, MD, Betty C. Tong, MD, MS, MHS
Screening and Early Detection of Lung Cancer is a topic covered in the Pearson's General Thoracic.

To view the entire topic, please log in or purchase a subscription.

STS Cardiothoracic Surgery E-Book from The Society of Thoracic Surgeons provides expert guidance for Cardiac and Thoracic Surgery. Sections include Pearson’s General Thoracic, Esphageal, Adult Cardiac, and Pediatric and Congenital Cardiac Surgery. Explore these free sample topics:

STS Cardiothoracic Surgery

Ventricular Septal Defects (VSD)Ventricular Septal Defects (VSD)

Laparoscopic Techniques in Reoperation for Failed Antireflux RepairLaparoscopic Techniques in Reoperation for Failed Antireflux Repair

Coronary Artery Bypass without CPBCoronary Artery Bypass without CPB

Diagnosis and Staging of Lung CancerDiagnosis and Staging of Lung Cancer

Nomenclature for Pediatric and Congenital Cardiac Care: Unification of Clinical and Administrative NomenclatureNomenclature for Pediatric and Congenital Cardiac Care: Unification of Clinical and Administrative Nomenclature

-- The first section of this topic is shown below --

Key Points

  • Historical studies of lung cancer screening utilized plain chest radiography (CXR) and sputum analysis, neither of which were effective in reducing lung cancer mortality.
  • Contemporary studies of lung cancer screening with low-dose computed tomography (LDCT) have demonstrated significant reduction in lung cancer mortality.
  • There are sex-based differences in mortality reduction when using LDCT lung cancer screening.
  • Barriers exist in recruitment and retention of patients qualified for LDCT lung cancer screening.
  • Adjuncts to radiographic screening, including biomarkers and radiomic analysis of screen-detected lesions, are currently being studied.

-- To view the remaining sections of this topic, please log in or purchase a subscription --

Key Points

  • Historical studies of lung cancer screening utilized plain chest radiography (CXR) and sputum analysis, neither of which were effective in reducing lung cancer mortality.
  • Contemporary studies of lung cancer screening with low-dose computed tomography (LDCT) have demonstrated significant reduction in lung cancer mortality.
  • There are sex-based differences in mortality reduction when using LDCT lung cancer screening.
  • Barriers exist in recruitment and retention of patients qualified for LDCT lung cancer screening.
  • Adjuncts to radiographic screening, including biomarkers and radiomic analysis of screen-detected lesions, are currently being studied.

There's more to see -- the rest of this entry is available only to subscribers.

© 2022 The Society of Thoracic Surgeons and Unbound Medicine, Inc. All Rights Reserved.